UB Paderborn / Katalog / Suche / in CDI

HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis

The Lancet infectious diseases, 2018-03, Vol.18 (3), p.346-355

2018

Link zum Volltext

Verfügbarkeit prüfen

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment

PLoS pathogens, 2020-08, Vol.16 (8), p.e1008791-e1008791

2020

Link zum Volltext

Verfügbarkeit prüfen

Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection

Science (American Association for the Advancement of Science), 2014-08, Vol.345 (6196), p.570-573

2014

Link zum Volltext

Verfügbarkeit prüfen

Food insecurity, drug resistance and non-disclosure are associated with virologic non-suppression among HIV pregnant women on antiretroviral treatment

PloS one, 2021-08, Vol.16 (8), p.e0256249-e0256249

2021

Link zum Volltext

Verfügbarkeit prüfen

Low rate of SARS-CoV-2 incident infection identified by weekly screening PCR in a prospective year-long cohort study

PloS one, 2022-09, Vol.17 (9), p.e0274078-e0274078

2022

Link zum Volltext

Verfügbarkeit prüfen

Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study

PloS one, 2019-10, Vol.14 (10), p.e0223411-e0223411

2019

Link zum Volltext

Verfügbarkeit prüfen

Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term

PloS one, 2022-09, Vol.17 (9), p.e0275254

2022

Link zum Volltext

Verfügbarkeit prüfen

Correlates of HIV detection among breastfeeding postpartum Kenyan women eligible under Option B

PloS one, 2019-05, Vol.14 (5), p.e0216252-e0216252

2019

Link zum Volltext

Verfügbarkeit prüfen

Simplified Paper Format for Detecting HIV Drug Resistance in Clinical Specimens by Oligonucleotide Ligation

PloS one, 2016, Vol.11 (1), p.e0145962-e0145962

2016

Link zum Volltext

Verfügbarkeit prüfen

The Clinical Implications of Pretreatment Drug Resistance-A Moving Target

Clinical infectious diseases, 2019-07, Vol.69 (2), p.215-217

2019

Link zum Volltext

Verfügbarkeit prüfen

Clonal Expansion of Human Immunodeficiency Virus—Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy

The Journal of infectious diseases, 2017-03, Vol.215 (suppl_3), p.S119-S127

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

The Lancet (British edition), 2021-04, Vol.397 (10281), p.1276-1292

2021

Link zum Volltext

Verfügbarkeit prüfen

HIV Transmission Through Premastication

Pediatrics (Evanston), 2022-10, Vol.150 (4), p.1

2022

Link zum Volltext

Verfügbarkeit prüfen

An Increasing Proportion of Monotypic HIV-1 DNA Sequences during Antiretroviral Treatment Suggests Proliferation of HIV-Infected Cells

Journal of Virology, 2013-02, Vol.87 (3), p.1770-1778

2013

Link zum Volltext

Verfügbarkeit prüfen

The role of HIV biology in defining virological failure

The lancet HIV, 2024-03, Vol.11 (3), p.e133-e134

2024

Link zum Volltext

Verfügbarkeit prüfen

Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort

PLoS medicine, 2018-03, Vol.15 (3), p.e1002537-e1002537

2018

Link zum Volltext

Verfügbarkeit prüfen

A Population-Based Study of Primary Human Herpesvirus 6 Infection

The New England journal of medicine, 2005-02, Vol.352 (8), p.768-776

2005

Link zum Volltext

Verfügbarkeit prüfen

Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge

PloS one, 2021-04, Vol.16 (4), p.e0240495-e0240495

2021

Link zum Volltext

Verfügbarkeit prüfen

Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants

Clinical infectious diseases, 2022-06, Vol.74 (11), p.2001-2009

2022

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection

PloS one, 2011-12, Vol.6 (12), p.e28952-e28952

2011

Link zum Volltext

Verfügbarkeit prüfen

Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapy

AIDS (London), 2022-11, Vol.36 (14), p.1949-1958

2022

Link zum Volltext

Verfügbarkeit prüfen

CRISPR/Cas9-Mediated Insertion of HIV Long Terminal Repeat within BACH2 Promotes Expansion of T Regulatory-like Cells

The Journal of immunology (1950), 2022-04, Vol.208 (7), p.1700-1710

2022

Link zum Volltext

Verfügbarkeit prüfen

Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes

The New England journal of medicine, 2011-10, Vol.365 (14), p.1284-1292

2011

Link zum Volltext

Verfügbarkeit prüfen

Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption

Cell reports (Cambridge), 2022-04, Vol.39 (4), p.110739-110739, Article 110739

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment

Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection

Food insecurity, drug resistance and non-disclosure are associated with virologic non-suppression among HIV pregnant women on antiretroviral treatment

Low rate of SARS-CoV-2 incident infection identified by weekly screening PCR in a prospective year-long cohort study

Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study

Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term

Correlates of HIV detection among breastfeeding postpartum Kenyan women eligible under Option B

Simplified Paper Format for Detecting HIV Drug Resistance in Clinical Specimens by Oligonucleotide Ligation

The Clinical Implications of Pretreatment Drug Resistance-A Moving Target

Clonal Expansion of Human Immunodeficiency Virus—Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy

HIV Transmission Through Premastication

An Increasing Proportion of Monotypic HIV-1 DNA Sequences during Antiretroviral Treatment Suggests Proliferation of HIV-Infected Cells

The role of HIV biology in defining virological failure

Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort

A Population-Based Study of Primary Human Herpesvirus 6 Infection

Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge

Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants

Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection

Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapy

CRISPR/Cas9-Mediated Insertion of HIV Long Terminal Repeat within BACH2 Promotes Expansion of T Regulatory-like Cells

Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes

HIV Drug Resistance Patterns and Characteristics Associated with Clinically Significant Drug Resistance among Children with Virologic Failure on Antiretroviral Treatment in Kenya: Findings from the Opt4Kids Randomized Controlled Trial

Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption

Suchergebnisse filtern